Assessment of the Quality of Life of Geriatric Patients with Parkinson’s Disease Being Rehabilitated and Improved in the Psychogeriatrics Department
DOI:
https://doi.org/10.15225/PNN.2025.14.1.5Keywords
geriatrics, mental health, quality of life, rehabilitationAbstract
Introduction. Parkinson’s disease is a progressive neurodegenerative disorder leading to the gradual deterioration of motor skills and the occurrence of emotional and somatic disorders.
Aim. The objective of this paper is to assess the psychophysical state and quality of life of geriatric patients with Parkinson’s disease who are being rehabilitated at the psychogeriatric department, as well as to get acquainted with this very disease and its course.
Material and Methods. The assessment has involved 100 geriatric patients with Parkinson’s disease. The research tool applied to determine the clinical condition was a questionnaire consisting of the author’s questionnaire, personal information, as well as the Hoehn–Yahr stage and the Polish version of the Short Form Health Survey (SF-36).
Results. The analysis of the conducted research concluded that patients with Parkinson’s disease display a low assessment of their quality of life and an impaired functioning in everyday life. Regarding physical activity, 65% of respondents believe that rehabilitation and regular physical activity have a positive impact on their health and quality of life.
Conclusions. Parkinson’s disease has a negative impact on the psychophysical condition as well as quality of life of patients and limits the performance of everyday activities that require energy. Rehabilitation and physical activity have a positive impact on the health of patients, improving their mental and physical condition and quality of life. (JNNN 2025;14(1):35–42)
References
[1] Mejnartowicz J.P., Badura-Stronka M. Diagnostyka neurogenetyczna. W: Kozubski W. (Red.), Neurologia. Podręcznik dla studentów medycyny. Wyd. Lekarskie PZWL, Warszawa 2023;164–169.
[2] Armstrong M.J., Okun M.S. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA. 2020;323(6):548–560.
[3] Lemieszewska M., Zabłocka A., Rymaszewska J. Choroba Parkinsona — etiopatogeneza, podłoże molekularne i potencjalne możliwości terapii. Postepy Hig Med Dosw. 2019;73:256–268.
[4] Reuter I. Choroba Parkinsona. Edra Urban & Partner, Wrocław 2019.
[5] Dutkiewicz J., Friedman A. Diagnostyka zaburzeń autonomicznych w chorobie Parkinsona. Wiad Lek. 2020;73(4):809–813.
[6] Pytel A., Kozłowska E., Kołtuniuk A., Rosińczuk J., Kazimierska-Zając M. Zaburzenia połykania w chorobie Parkinsona. Gerontol Pol. 2019;27:66–71.
[7] Barcikowska M. Zaburzenia otępienne. W: Cybulski M., Krajewska-Kułak E. (Red.), Wielkie zespoły geriatryczne. Edra Urban & Partner, Wrocław 2021;17–19.
[8] Rusz J., Krupička R., Vítečková S. et al. Speech and gait abnormalities in motor subtypes of de-novo Parkinson’s disease. CNS Neurosci Ther. 2023;29(8):2101–2110.
[9] Fife B. Jak pokonać Alzheimera, Parkinsona, SM i inne choroby neurodegeneracyjne. Zapobieganie, leczenie, cofanie skutków. Vital, Białystok 2014.
[10] Mendel T.A. Choroba Parkinsona. W: Wieczorowska-Tobis K., Talarska D. (Red.), Geriatria i pielęgniarstwo geriatryczne. Wyd. Lekarskie PZWL, Warszawa 2017;117–122.
[11] Lorencowicz R., Jasik J., Podkowiński A., Ruchała M., Przychodzka E., Brzozowska A. Wybrane uwarunkowania jakości życia w chorobie Parkinsona. Pielęg Neurol Neurochir. 2012;1(2):48–57.
[12] Leszko M., Zając-Lamparska L. Choroba Parkinsona. W: Zych A.A. (Red.), Encyklopedia starości, starzenia się i niepełnosprawności. Tom 1, Stowarzyszenie Thesaurus Silesiae — Skarb Śląski, Katowice 2017;232–235.
[13] Marusiak J. Czy intensywny wysiłek fizyczny może być lekiem w chorobie Parkinsona? Kosmos. 2020;69(4):631–638.
[14] Jin X., Wang L., Liu S., Zhu L., Loprinzi P.D., Fan X. The Impact of Mind-body Exercises on Motor Function, Depressive Symptoms, and Quality of Life in Parkinson’s Disease: A Systematic Review and Meta-analysis. Int J Environ Res Public Health. 2019;17(1):31.
[15] Bonacina D., Tosatto D., Ugolini A. et al. Spatiotemporal, kinematic and kinetic gait characteristics in Parkinson’s disease compared to healthy individuals: A systematic review with meta-analysis. Clin Biomech (Bristol). 2024;120:106359.
[16] Wróbel A., Wróbel P., Otfinowska E. Znaczenie wsparcia oraz formy aktywności kinezyterapeutycznej członków rodzin osób dotkniętych chorobą Parkinsona. Health Prom Phys Act. 2019;1(6):1–7.
[17] Cybulski M., Waszkiewicz N., Krajewska-Kułak E., Kędziora-Kornatowska K. (Red.), Psychogeriatria. PZWL, Warszawa 2017.
[18] Zhao N., Yang Y., Zhang L. et al. Quality of life in Parkinson’s disease: A systematic review and meta-analysis of comparative studies. CNS Neurosci Ther. 2021;27(3):270–279.
[19] Augustyniuk K., Knapik J., Starczewska M., Schneider-Matyka D., Szkup M., Jurczak A. Ocena wpływu działań fizjoterapeutycznych i czasu trwania choroby na jakość życia pacjenta z chorobą Parkinsona. Fam Med Prim Care Rev. 2016;18(2):99–102.
[20] Cholewa J., Gorzkowska A., Nawrocka A., Cholewa J. Jakość życia osób z chorobą Parkinsona w kontekście pracy zawodowej i rehabilitacji ruchowej. Med Pr. 2017;68(6):725–734.
[21] Tosin M.H., Goetz C.G., Stebbins G.T. Patient With Parkinson Disease and Care Partner Perceptions of Key Domains Affecting Health-Related Quality of Life: Systematic Review. Neurology. 2024;102(3):e208028.
[22] Jost S.T., Aloui S., Evans J. et al. Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years: A Nonrandomized Controlled Trial. JAMA Netw Open. 2024;7(1):e2352177.
[23] Shalash A., Roushdy T., Essam M. et al. Mental Health, Physical Activity, and Quality of Life in Parkinson’s Disease During COVID-19 Pandemic. Mov Disord. 2020;35(7):1097–1099.
[24] Franzén E., Johansson H., Freidle M. et al. The EXPANd trial: effects of exercise and exploring neuroplastic changes in people with Parkinson’s disease: a study protocol for a double-blinded randomized controlled trial. BMC Neurol. 2019;19(1):280.
[25] Shi C., Zheng Z., Wang Q. et al. Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson’s Disease Assessed by the Unified Parkinson’s Disease Rating Scale and the Hoehn-Yahr Stage. PLoS One. 2016;11(6):e0155758.
[26] Opara J.A., Brola W., Leonardi M., Błaszczyk B. Quality of life in Parkinson’s disease. J Med Life. 2012;5(4):375–381.
[27] Martinez-Martin P., Jeukens-Visser M., Lyons K.E. et al. Health-related quality-of-life scales in Parkinson’s disease: critique and recommendations. Mov Disord. 2011;26(13):2371–2380.
[28] Rubenstein L.M., Voelker M.D., Chrischilles E.A., Glenn D.C., Wallace R.B., Rodnitzky R.L. The usefulness of the Functional Status Questionnaire and Medical Outcomes Study Short Form in Parkinson’s disease research. Qual Life Res. 1998;7(4):279–290.
[29] Dutkiewicz J., Friedman A. Diagnostyka zaburzeń autonomicznych w chorobie Parkinsona. Wiad Lek. 2020;73(4):809–813.
[30] Kataoka H., Sugie K. Health-Related Quality of Life May Predict Disease Staging in 10 Years in Parkinson Disease With Hoehn-Yahr Stage III. Neurol Clin Pract. 2021;11(3):e261–e266.
[31] Forsaa E.B., Larsen J.P., Wentzel-Larsen T., Herlofson K., Alves G. Predictors and course of health-related quality of life in Parkinson’s disease. Mov Disord. 2008;23(10):1420–1427.
[32] Qin Z., Zhang L., Sun F. et al. Health related quality of life in early Parkinson’s disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord. 2009;15(10):767–771.
[33] Pazzaglia C., Imbimbo I., Tranchita E. et al. Comparison of virtual reality rehabilitation and conventional rehabilitation in Parkinson’s disease: a randomised controlled trial. Physiotherapy. 2020;106:36–42.
[34] Tu X.J., Hwang W.J., Hsu S.P., Ma H.I. Responsiveness of the short-form health survey and the Parkinson’s disease questionnaire in patients with Parkinson’s disease. Health Qual Life Outcomes. 2017;15(1):75.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Aleksandra Szabert-Kajkowska, Marcin Trębowicz, Joanna Łuczak, Natalia Brudnicka1
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 223
Number of citations: 0